Diamond-Blackfan anemia
MONDO:0015253A congenital aregenerative and often macrocytic anemia with erythroblastopenia.
Also known as: Aase syndrome, Aase-Smith II syndrome, Blackfan-Diamond anaemia, Blackfan-Diamond anemia, DBA, Diamond Blackfan Anemia, Diamond-Blackfan anemia, chronic constitutional pure red cell anemia
26 clinical trials for this condition and its sub-types, 17 tagged with Diamond-Blackfan anemia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Diamond-Blackfan anemia
-
Diamond-Blackfan anemia 1 1 trial
-
Diamond-Blackfan anemia 10 0 trials
-
Diamond-Blackfan anemia 11 0 trials
-
Diamond-Blackfan anemia 12 0 trials
-
Diamond-Blackfan anemia 13 0 trials
-
Diamond-Blackfan anemia 16 0 trials
-
Diamond-Blackfan anemia 17 0 trials
-
Diamond-Blackfan anemia 18 0 trials
-
Diamond-Blackfan anemia 19 0 trials
-
Diamond-Blackfan anemia 2 0 trials
-
Diamond-Blackfan anemia 20 0 trials
-
Diamond-Blackfan anemia 21 0 trials
-
Diamond-Blackfan anemia 22 0 trials
-
Diamond-Blackfan anemia 3 0 trials
-
Diamond-Blackfan anemia 4 0 trials
-
Diamond-Blackfan anemia 5 0 trials
-
Diamond-Blackfan anemia 6 0 trials
-
Diamond-Blackfan anemia 7 0 trials
-
Diamond-Blackfan anemia 8 0 trials
-
Diamond-Blackfan anemia 9 0 trials
-
New drug combo aims to make bone marrow transplants safer for kids
Disease control OngoingThis pilot study tests a fludarabine-based drug regimen to prepare children with bone marrow failure syndromes for a bone marrow transplant from a matched sibling donor. The goal is to help the donor cells successfully take root while reducing serious side effects. The study incl…
Early phase 1 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New blood treatment could block zika in transfusions
Disease control OngoingThis study tests a special treatment for red blood cells that aims to kill the Zika virus, making transfusions safer. About 692 people who need blood transfusions will receive either treated or standard blood. The goal is to see if the treated blood works just as well and is safe…
Phase 3 • Sponsor: Cerus Corporation • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New algorithm aims to catch ovarian damage early in young cancer survivors
Knowledge-focused CancelledThis study was designed to see if a new monitoring algorithm could detect early signs of ovarian damage in women and girls who had cancer treatment. Researchers planned to compare a group using the new algorithm with a group that received standard care. However, the study was wit…
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:42 UTC